ISO 18362:2016
2016-02
Résumé
ISO 18362:2016 specifies the minimum requirements for, and provides guidance on, a risk-based approach for the processing of cell-based health care products (CBHPs) requiring control of viable and non-viable microbial contamination. It is applicable both to CBHPs labelled 'sterile' and to CBHPs not labelled 'sterile'.
ISO 18362:2016 is not applicable to:
- procurement and transport of cell-based starting material used in processing of a CBHP,
- cell banking,
- control of genetic material,
- control of non-microbial product contamination,
- in vitro diagnostics (IVDs), or
- natural medicines.
EXAMPLE Vitamins and minerals, herbal remedies, homoeopathic medicines, traditional medicines such as traditional Chinese medicines, probiotics, other products such as amino acids and essential fatty acids.
ISO 18362:2016 does not define biosafety containment requirements.
ISO 18362:2016 does not replace national or regional regulations that apply to the manufacture and quality control of a CBHP.
Informations générales
-
État actuel: PubliéeDate de publication: 2016-02Stade: Norme internationale confirmée [90.93]
-
Edition: 1
-
Comité technique :ISO/TC 198ICS :11.080.01
- RSS mises à jour
Amendements
Des amendements sont publiés lorsqu’il s’avère que de nouveaux éléments doivent être ajoutés à un document normatif existant. Ils peuvent également inclure des corrections d’ordre rédactionnel ou technique à appliquer au document en vigueur.
Amendement 1
Edition 2022
Cycle de vie
-
Actuellement
-
00
Préliminaire
-
10
Proposition
-
20
Préparation
-
30
Comité
-
40
Enquête
-
50
Approbation
-
60
Publication
-
90
Examen
-
95
Annulation
Amendements
Proposent un contenu additionnel; disponibles à l’achat; non inclus dans le texte de la norme en vigueur.PubliéeISO 18362:2016/Amd 1:2022
-
00
